Topical or Oral Minoxidil for Hair Loss in Breast Cancer Patients
This study is looking at whether minoxidil, a drug that can help with hair growth, can treat hair loss caused by endocrine therapy in patients with stage I-IV breast cancer. Many women on endocrine therapy (like tamoxifen or aromatase inhibitors) experience hair loss, which can be distressing. Researchers want to see if taking minoxidil by mouth works as well as applying it to the scalp. This early-phase study will also look at how safe and tolerable low-dose oral minoxidil is. You may be able to join if you are a woman aged 18 or older with breast cancer (stages I-IV), are on endocrine therapy, and have noticed hair loss since starting treatment. The main goal is to see how consistently participants take or apply their assigned medication over 12 months.
- Study design
- This is an interventional study where 50 participants will be randomly assigned to one of two groups: one applying minoxidil foam to the scalp, and the other taking minoxidil by mouth.
- What's involved
- You would either apply minoxidil foam to your scalp once daily or take minoxidil by mouth once daily for up to 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will measure how consistently you take or apply your medication for up to 12 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Brittany L Dulmage, MD · PRINCIPAL_INVESTIGATOR · Ohio State University Comprehensive Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Proportion of days assigned medication was taken/appliedUp to 12 months
For the oral minoxidil group, the proportion of pills taken will be reported with a 95% confidence interval. For the topical minoxidil group, the proportions of days medication was applied will be reported with a 95% confidence interval.